Allianz Asset Management
ATRS

Allianz Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Allianz Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,684
Closed -$60K – 2729
2021
Q4 		$60K Sell
16,684
-10
-0.1% -$35 ﹤0.01% 2521
2021
Q3 		$61K Buy
16,694
+1,380
+9% +$5.58K ﹤0.01% 2525
2021
Q2 		$67K Buy
15,314
+177
+1% +$721 ﹤0.01% 2365
2021
Q1 		$62K Sell
15,137
-2,953
-16% -$12.8K ﹤0.01% 2146
2020
Q4 		$72K Sell
18,090
-1,351
-7% -$4.37K ﹤0.01% 1830
2020
Q3 		$52K Sell
19,441
-5,751
-23% -$15.9K ﹤0.01% 1823
2020
Q2 		$69K Sell
25,192
-365,715
-94% -$1.02M ﹤0.01% 2353
2020
Q1 		$923K Sell
390,907
-3,251
-0.8% -$11.1K ﹤0.01% 1832
2019
Q4 		$1.85M Buy
394,158
+10,752
+3% +$44K ﹤0.01% 1905
2019
Q3 		$1.28M Sell
383,406
-461,697
-55% -$1.52M ﹤0.01% 2019
2019
Q2 		$2.78M Buy
845,103
+337
+0% +$975 ﹤0.01% 1762
2019
Q1 		$2.56M Sell
844,766
-8,167
-1% -$26.5K ﹤0.01% 1757
2018
Q4 		$2.32M Sell
852,933
-38,353
-4% -$126K ﹤0.01% 1713
2018
Q3 		$3M Buy
891,286
+132,113
+17% +$408K ﹤0.01% 1790
2018
Q2 		$1.96M Sell
759,173
-3,838
-0.5% -$9.55K ﹤0.01% 1951
2018
Q1 		$1.68M Sell
763,011
-13,193
-2% -$29.7K ﹤0.01% 2000
2017
Q4 		$1.54M Sell
776,204
-10,036
-1% -$21.8K ﹤0.01% 2101
2017
Q3 		$2.55M Buy
786,240
+12,402
+2% +$38.3K ﹤0.01% 1915
2017
Q2 		$2.49M Buy
+773,838
New +$2.19M ﹤0.01% 1906
2014
Q3 		– Sell
-400,000
Closed -$1.07M – 2387
2014
Q2 		$1.07M Sell
400,000
-1,435,234
-78% -$4.32M ﹤0.01% 1376
2014
Q1 		$6.42M Buy
1,835,234
+132,080
+8% +$586K 0.01% 881
2013
Q4 		$7.63M Buy
1,703,154
+193,528
+13% +$789K 0.01% 825
2013
Q3 		$6.13M Buy
1,509,626
+49,471
+3% +$216K 0.01% 853
2013
Q2 		$6.07M Buy
+1,460,155
New +$5.64M 0.01% 819

Other funds holding ATRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Allianz Asset Management's ATRS Position: Q1 2022 in Review

Allianz Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2022, closing a stake of 16,684 shares — an estimated $60K sold.

Allianz Asset Management first reported a position in ATRS in Q2 2013 and held it in 24 quarters. The position peaked at $7.63M in Q4 2013. 177 funds tracked by Wall St. Rank hold ATRS as of Q1 2022.

  • Allianz Asset Management reported no remaining Antares Pharma, Inc. position as of Q1 2022 after selling out during the quarter.
  • Allianz Asset Management sold 16,684 Antares Pharma, Inc. shares in Q1 2022, an estimated $60K.
  • Allianz Asset Management first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 24 quarters.
  • Allianz Asset Management's Antares Pharma, Inc. position peaked at $7.63M in Q4 2013.
  • 177 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2022.

Based on Allianz Asset Management's 13F filing for Q1 2022, filed 13 May 2022.